Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruiting
NCT07354074Phase 2Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
United States, Australia, Brazil, Canada, China +8 more
DEXA Bone Density Analysis of the CoreHip® Prosthesis SystemNot Yet Recruiting
NCT06632301NAUpdated Aug 20, 2026
Sponsor: Aesculap AG
Primary Osteoarthritis · Cartilage Degeneration · Osteoarthritis, Hip · Inflammatory Arthritis
Germany
Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALSTerminated
NCT05151471Phase 3Updated Aug 20, 2026
Sponsor: Shionogi
ALS
United States, Canada, Germany, Japan, South Korea +1 more
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.Active Not Recruiting
NCT06247995Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, Australia, Canada, China, France +6 more
Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLLActive Not Recruiting
NCT04515238Phase 2Updated Aug 20, 2026
Sponsor: German CLL Study Group
Chronic Lymphoid Leukemia
Germany
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]Recruiting
NCT06422143Phase 3Updated Aug 20, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer · NSCLC
United States, Argentina, Austria, Brazil, Canada +21 more
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia GravisCompleted
NCT04650854Phase 3Updated Aug 20, 2026
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
United States, Canada, Czechia, Denmark, France +9 more
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular PatchesRecruiting
NCT04545502N/AUpdated Aug 20, 2026
Sponsor: Vascutek Ltd.
Aneurysm · Dissection · Aortic Root Aneurysm · Aortic Root Dissection
United States, Belgium, France, Germany, Hungary +1 more
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Active Not Recruiting
NCT04886804Phase 1Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Neoplasm Metastasis · Non-Small Cell Lung Cancer
United States, Australia, Austria, Belgium, China +13 more
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)Active Not Recruiting
NCT04497844Phase 3Updated Aug 20, 2026
Sponsor: Janssen Research & Development, LLC
Metastatic Castration-sensitive Prostate Cancer
United States, Argentina, Australia, Belarus, Belgium +28 more
Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaRecruiting
NCT07170917Phase 2Updated Aug 20, 2026
Sponsor: Sanofi
Hidradenitis Suppurativa
United States, Australia, Canada, Chile, China +14 more
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaRecruiting
NCT07129993Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: Daiichi Sankyo
Urothelial Cancer · Bladder Cancer
United States, Austria, China, France, Germany +2 more
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)Active Not Recruiting
NCT05993234N/AUpdated Aug 20, 2026
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
HER2-positive Advanced Gastric Cancer · HER2-positive Gastroesophageal Junction Adenocarcinoma
Austria, Belgium, Germany, Italy
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistaminesActive Not Recruiting
NCT05976243Phase 3Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Inducible Urticaria
United States, Argentina, Australia, Brazil, Canada +23 more
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy ParticipantsRecruiting
NCT06577337Phase 1Updated Aug 20, 2026
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Healthy
Germany
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)Active Not Recruiting
NCT05649748Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: Insmed Incorporated
Pulmonary Arterial Hypertension
United States, Argentina, Austria, Belgium, Brazil +10 more
Shift Workers' Health Behavior Action Program Across EuropeRecruiting
NCT07631767NAUpdated Aug 20, 2026
Sponsor: Wageningen University
Night Shift Work · Obesity & Overweight · Circadian Misalignment
Germany, Netherlands, Poland
Pivotal Study of N-acetyl-L-leucine for CACNA1ARecruiting
NCT07221292Phase 3Updated Aug 20, 2026
Sponsor: IntraBio Inc
CACNA1A · Spinocerebellar Ataxia Type 6 · Episodic Ataxia Type 2 · Familial Hemiplegic Migraine-1
United States, Austria, Germany, Greece, Italy +2 more
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary HemochromatosisRecruiting
NCT07332091Phase 2Updated Aug 20, 2026
Sponsor: CSL Behring
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
United States, Australia, Austria, Belgium, Canada +13 more
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT06819878Phase 3Updated Aug 20, 2026
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Crohns Disease
United States, Argentina, Australia, Austria, Belgium +33 more
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseRecruiting
NCT06976216Phase 3Updated Aug 20, 2026
Sponsor: Bristol-Myers Squibb
Alzheimer's Disease
United States, Argentina, Australia, Brazil, Canada +14 more
Total Shoulder Arthroplasty Multi-Center RegistryRecruiting
NCT03511586N/AUpdated Aug 20, 2026
Sponsor: Arthrex, Inc.
Shoulder Arthroplasty
United States, Germany, Switzerland, United Kingdom
Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaTerminated
NCT05724602Phase 2Updated Aug 20, 2026
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Locally Advanced Head and Neck Squamous Cell Carcinoma
Belgium, France, Germany, Ireland, Italy +5 more
Measuring Corneal ParametersRecruiting
NCT07629232NAUpdated Aug 20, 2026
Sponsor: Icare Finland Oy
Corneal Parameters
Germany
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisRecruiting
NCT06470048Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
United States, Argentina, Austria, Belgium, Brazil +20 more

Previous page Next page